High-dose folic acid supplements and responsiveness to rHu-EPO in HD patients.

vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant 2005; 20: 1874–1879 2. You SA, Wang Q. Ferritin in atherosclerosis. Clin Chim Acta 2005; 357: 1–16 3. Puntarulo S. Iron, oxidative stress and human health. Mol Aspects Med 2005; 26: 299–312 4. Kletzmayr J, Horl WH. Iron overload and cardiovascular complications in dialysis patients. Nephrol Dial Transplant 2002; 17 [Suppl 2]: 25–29 5. Lim PS, Wei YH, Yu YL, Kho B. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant 1999; 14: 2680–2687 6. Fishbane S, Kalantar-Zadeh K, Nissenson AR. Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment. Semin Dial 2004; 17: 336–341 7. Reddi AS, Bollineni JS, Baskin S, Nimmagadda VR, Baker H. Serum ferritin and oxidative stress in patients undergoing hemodialysis. Nephron 2000; 86: 202–203 8. Lim PS, Chan EC, Lu TC et al. Lipophilic antioxidants and iron status in ESRD patients on hemodialysis. Nephron 2000; 86: 428–435

[1]  H. Schiffl,et al.  Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  Z. Massy,et al.  Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  I. Ahmed,et al.  A fatal fungus. , 2005, Annals of Thoracic Surgery.

[4]  A. Bener,et al.  Epidemiology, presentation, management and outcome of candidemia in a tertiary care teaching hospital in the United Arab Emirates, 1995-2001. , 2003, Medical mycology.

[5]  P. Pappas,et al.  Current concepts in the management of fungal peritonitis , 2003, Current infectious disease reports.

[6]  C. Hawley,et al.  Sclerosing peritonitis: the experience in Australia. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  J. Bradley,et al.  SCLEROSING PERITONITIS AFTER CAPD , 1983, The Lancet.

[8]  H. Baddeley,et al.  Sclerosing peritonitis due to practolol: A report on 9 cases and their surgical management , 1977, The British journal of surgery.

[9]  H. Baddeley,et al.  Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). , 1974, Lancet.